Tag: hikma

Boehringer to sell stake in Hikma

by Selina McKee | Jun 23, 2020 | News | 0

Boehringer’s stake in the firm equates to around 16.4%

Hikma, Arecor set to co-develop new injectable meds

by Anna Smith | Jan 9, 2020 | News | 0

The product will be officially announced prior to launch.

Hikma, Vectura to develop generic rivals to GSK’s Ellipta portfolio

by Selina McKee | Nov 9, 2018 | News | 0

Hikma Pharmaceuticals and Vectura have signed a deal to develop and market generic versions of GlaxoSmithKline’s Ellipta portfolio, utilising the latter’s Open-Inhale-Close dry powder inhaler device.

Hikma/Vectura’s generic Advair delayed in the US

by Selina McKee | Mar 12, 2018 | News | 0

US regulators have upheld a prior decision rejecting Hikma and Vectura’s generic formulation of GlaxoSmithKline’s asthma and chronic obstructive pulmonary syndrome therapy Advair Diskus.

Setback for Vectura/Hikma’s Advair Diskus generic

by Selina McKee | May 11, 2017 | News | 0

Chippenham, UK-based Vectura and its partner Hikma Pharmaceuticals have announced a major setback in the US after VR315, a generic version of GlaxoSmithKline’s asthma/COPD inhaler Advair Diskus, was rejected by the FDA.